Katharina C. Kaehler, Mirjana Ziemer, Jessica Cecile Hassel, Piotr Rutkowski, Friedegund Elke Meier, Lukas Flatz, Caroline Gaudy-Marqueste, Mario Santinami, Francesco Russano, Imke von Wasielewski, Thomas Eigentler, Michele Maio, Iris Zalaudek, Sebastian Haferkamp, Pietro Quaglino, Julia Welzel, Paolo Antonio Ascierto, Caroline Robert, Dirk Schadendorf, Axel Hauschild. "Neoadjuvant intralesional daromun (L19IL2/L19TNF) in resectable locally advanced melanoma: An update on the primary outcome and sensitivity analyses (EFS) from the PIVOTAL phase 3 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.17_suppl.lba9517